# TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects

> **NCT03675880** · PHASE1 · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 24 (estimated)

## Conditions studied

- AMD

## Interventions

- **DRUG:** TAB014

## Key facts

- **NCT ID:** NCT03675880
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-15
- **Primary completion:** 2019-02-15
- **Final completion:** 2019-04-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03675880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03675880, "TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03675880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*